Kv1.3 channels: Therapeutic target for T cell-mediated autoimmune diseases

被引：0
|
作者：
Monaghan, Kevin P.
Beeton, Christine
Wulff, Heike
Calabresi, Peter
Chandy, George K.
机构：
来源：
NEUROLOGY | 2007年 / 68卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A339 / A340
页数：2
相关论文
共 50 条
  • [1] Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
    Beeton, Christine
    Wulff, Heike
    Standifer, Nathan E.
    Azam, Philippe
    Mullen, Katherine M.
    Pennington, Michael W.
    Kolski-Andreaco, Aaron
    Wei, Eric
    Grino, Alexandra
    Counts, Debra R.
    Wang, Ping H.
    LeeHealey, Christine J.
    Andrews, Brian S.
    Sankaranarayanan, Ananthakrishnan
    Homerick, Daniel
    Roeck, Werner W.
    Tehranzadeh, Jamshid
    Stanhope, Kimber L.
    Zimin, Pavel
    Havel, Peter J.
    Griffey, Stephen
    Knaus, Hans-Guenther
    Nepom, Gerald T.
    Gutman, George A.
    Calabresi, Peter A.
    Chandy, K. George
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) : 17414 - 17419
  • [2] Kv1.3 channels: therapeutic target for T cell-mediated autoimmune diseases
    Beeton, C.
    Wulff, H.
    Standifer, N. E.
    Mullen, K. M.
    Azam, P.
    Kolski-Andreaco, A.
    Wei, E.
    Grino, A.
    Counts, D. R.
    Wang, P. H.
    LeeHealey, C. J.
    Andrews, B. S.
    Pennington, M. W.
    Knaus, H. G.
    Nepom, G. T.
    Gutman, G. A.
    Calabresi, P. A.
    Chandy, K. G.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S148 - S148
  • [3] Kv1.3: A promising target for the treatment of autoimmune diseases
    Tasler, Stefan
    Pruetting, Sylvia
    Hamm, Svetlana
    Dreker, Tobias
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [4] Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
    Rangaraju, Srikant
    Chi, Victor
    Pennington, Michael W.
    Chandy, K. George
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (08) : 909 - 924
  • [5] Kv1.3 blocking alkoxypsoralens -: A new class of immunomodulators for the treatment of T cell mediated autoimmune diseases?
    Beeton, C
    Vennekamp, J
    Wulff, H
    Chen, CY
    Ananthakrishnan, S
    Calabresi, PA
    Grissmer, S
    Hänsel, W
    Chandy, KG
    [J]. BIOPHYSICAL JOURNAL, 2004, 86 (01) : 538A - 538A
  • [6] Targeting Kv1.3 K+ channels in effector memory T cell for the therapy of autoimmune diseases.
    Beeton, C
    Wulff, H
    Pennington, MW
    Calabresi, PA
    Wang, PH
    LeeHealey, CJ
    Andrews, BS
    Chandy, KG
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S491 - S492
  • [7] Inhibition of Kv1.3 and IKCa1 lymphocyte potassium channels as a novel therapeutic strategy in T helper cell mediated diseases
    Toldi, G.
    Orban, C.
    Biro, E.
    Bajnok, A.
    Vasarhelyi, B.
    [J]. ALLERGY, 2013, 68 : 68 - 69
  • [8] Kv1.3 blockers for treatment of autoimmune diseases
    Tasler, Stefan
    Dreker, Tobias
    Kraus, Juergen
    Hamm, Svetlana
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [9] A small molecule Kv1.3 blocker, for the treatment of effector memory T-cell mediated autoimmune diseases.
    Azam, Philippe
    Sankaranarayanan, Ananthakrishnan
    Homerick, Daniel
    Wulff, Heike
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S45 - S46
  • [10] KV1.3 POTASSIUM CHANNELS: A ROLE IN WHITE MATTER INJURY AND A THERAPEUTIC TARGET
    Reeves, Thomas M.
    Colley, Beverly S.
    Trimmer, Patricia A.
    Phillip, Linda L.
    [J]. JOURNAL OF NEUROTRAUMA, 2013, 30 (15) : A14 - A15
12345